Based on differences in genetic and environmental risk factors between ACPA-positive and ACPA-negative RA, it has been suggested that different pathogenic pathways underlie seronegative and seropositive RA disease [31]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.